Anastrozole, a revolutionary breast cancer prevention drug, is now available for postmenopausal women at risk due to their family history. Anastrozole, described as “remarkable” by NHS leaders, is specifically designed for postmenopausal women with significant familial ties to breast cancer. It works by reducing the production of estrogen, a hormone that plays a key role in the development of breast cancer. In conclusion, the availability of Anastrozole as a preventive medicine marks a significant milestone in breast cancer prevention. By empowering postmenopausal women with a family history of breast cancer, we can potentially save thousands of lives and move closer to a future where breast cancer becomes a thing of the past.

Source: The Guardian November 07, 2023 12:12 UTC